Royal Bank of Canada’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $458K | Buy |
19,388
+18,338
| +1,746% | +$433K | ﹤0.01% | 4212 |
|
2025
Q1 | $25K | Sell |
1,050
-1,206
| -53% | -$28.7K | ﹤0.01% | 5461 |
|
2024
Q4 | $95K | Sell |
2,256
-3,065
| -58% | -$129K | ﹤0.01% | 4909 |
|
2024
Q3 | $235K | Buy |
5,321
+738
| +16% | +$32.6K | ﹤0.01% | 4264 |
|
2024
Q2 | $166K | Sell |
4,583
-2,267
| -33% | -$82.1K | ﹤0.01% | 4524 |
|
2024
Q1 | $297K | Sell |
6,850
-3,940
| -37% | -$171K | ﹤0.01% | 3951 |
|
2023
Q4 | $166K | Buy |
10,790
+5,199
| +93% | +$80K | ﹤0.01% | 4736 |
|
2023
Q3 | $77K | Buy |
5,591
+2,252
| +67% | +$31K | ﹤0.01% | 5067 |
|
2023
Q2 | $54K | Buy |
3,339
+1,625
| +95% | +$26.3K | ﹤0.01% | 5301 |
|
2023
Q1 | $13K | Sell |
1,714
-819
| -32% | -$6.21K | ﹤0.01% | 5824 |
|
2022
Q4 | $49K | Buy |
2,533
+1,862
| +277% | +$36K | ﹤0.01% | 5427 |
|
2022
Q3 | $15K | Buy |
671
+93
| +16% | +$2.08K | ﹤0.01% | 5773 |
|
2022
Q2 | $8K | Sell |
578
-763
| -57% | -$10.6K | ﹤0.01% | 6018 |
|
2022
Q1 | $32K | Sell |
1,341
-1,355
| -50% | -$32.3K | ﹤0.01% | 5870 |
|
2021
Q4 | $72K | Buy |
2,696
+1,916
| +246% | +$51.2K | ﹤0.01% | 5632 |
|
2021
Q3 | $13K | Buy |
+780
| New | +$13K | ﹤0.01% | 6355 |
|